Status:
COMPLETED
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
Lead Sponsor:
Galderma R&D
Conditions:
Acne
Eligibility:
All Genders
12-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with A...
Detailed Description
This study is a follow-up to RD.03.SPR.29074 - ACCESS I / NCT00688064 - "Adapalene-BPO Gel Associated With Doxycycline 100 mg in the Treatment of Severe Acne Vulgaris"
Eligibility Criteria
Inclusion
- Subjects who completed the previous study (RD.03.SPR29074 - NCT00688064)and had obtained at least a good Improvement (Grade, 0, 1, 2 or 3)
Exclusion
- Female Subjects who are pregnant, nursing or planning a pregnancy during the study
- Subjects who foresee intensive UV exposure during the study (mountain sports, UV radiation, sunbathing, etc).
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT00687908
Start Date
November 1 2008
End Date
July 1 2009
Last Update
February 18 2021
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Galderma Investigational Site
San Diego, California, United States
2
Galderma Investigational Site
Denver, Colorado, United States
3
Galderma Investigational Site
Longmont, Colorado, United States
4
Galderma Investigational Site
Miami, Florida, United States